Breast Cancer Detection App Gets FDA's Breakthrough Device Designation
Swathi Kodaikal, MSc
The application is the first of its kind to be recognized by the FDA
Cancer Screening
ACS Updates Lung Cancer Screening Guideline
American Cancer Society
The Society aims to reduce lung cancer deaths with updated screening recommendations
Seeking KRAS: An Optimized Protocol for Detecting KRAS Mutations
Thermo Fisher Scientific
Discover how Sanger sequencing helps detect KRAS mutations to inform oncological treatment and prognosis
Blood Test to Detect Cancer Early in High-Risk Families
The Hospital for Sick Children
Liquid biopsies help extract and screen circulating tumor DNA for cancer-causing anomalies well in advance
Ultrasensitive Blood Test Detects Multi-Cancer-Specific Biomarker
Mass General Brigham
Novel blood test detects the highly specific ORF1p biomarker found in multiple cancers
FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers
U.S. Food and Drug Administration
The new prescription test doesn’t identify or evaluate all known genes that may predispose an individual to cancer
Assessing Tumor Progression in Neuroendocrine Cancer Patients
Thermo Fisher Scientific
Thermo Fisher announces FDA-clearance of first-to-market automated assay
Are Risk-Based MCED Tests the Future of Cancer Screening?
Swathi Kodaikal, MSc
Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
Novel Test Helps Detect Often-Missed Cervical Adenocarcinoma
Albert Einstein College of Medicine
Women with a high DNA methylation score would be prone to HPV infection, AIS, and ADC
AI-Based Biomarker Prediction Accelerates CRC Prognosis
Helmholtz Zentrum München
New transformer network-based approach substantially improves the data efficiency and interpretability of colorectal cancer biopsies